RIO DE JANEIRO, BRAZIL - The Albert Einstein Israeli Hospital in São Paulo announced on Thursday, May 21st, that it had developed an unprecedented test for the novel coronavirus. The method ensures accuracy identical to RT-PCR, the most accurate test currently used, but with a higher volume of processing.
According to the hospital, the new model allows the concurrent performance of up to 1,536 samples, totaling a processing volume 16 times higher than in RT-PCR testing. The breakthrough is unprecedented in the world and was patented in the United States last week.
The test uses so-called . . .